Resisting american psychiatry: French opposition to DSM-III, biological reductionism, and the pharmaceutical ethos

Advances in Medical Sociology

Volumn 12, Issue , 2011, Pages 85-110

  Vallee, Manuel ^a  

^a NONE

Author keywords

ADHD; CFTMEA; Culture bound syndromes; Diagnostic reference manuals; DSM

Indexed keywords

EID: 84864788263     PISSN: 10576290     EISSN: None     Source Type: Book Series    
DOI: 10.1108/S1057-6290(2011)0000012009     Document Type: Article

References (74)

1. Abbott, A. D. (1988). The system of professions: An essay on the division of expert labor. Chicago, IL: The University of Chicago Press.
2. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., revised). Washington, DC: American Psychiatric Association.
3. Ash, P. (1949). The reliability of psychiatric diagnosis. Journal of Abnormal and Social Psychology, 44, 272-277.
4. Barkley, R. A. (2005). Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment (3rd ed.). New York, NY: Guilford Press.
5. Beiser, M. (1985). A study of depression among traditional Africans, urban North Americans, and Southeast Asian refugees. In: A. Kleinman & B. Good (Eds.), Culture and depression: Studies in the anthropology and cross-cultural psychiatry of affect and disorder (pp. 272-298). Berkeley, CA: University of California Press.
6. Bell, I. R., Edman, J. S., Marby, D. W., Satlin, A., Dreier, T., Liptzin, B., & Cole, J. O. (1990). Vitamin B-12 and folate status in acute geropsychiatric inpatients: Affective and cognitive characteristics of a vitamin nondeficient population. Biological Psychiatry, 27(2), 125-137. (Pubitemid 20033760)
7. Boris, M., & Mandel, F. S. (1994). Foods and additives are common causes of the attention deficit hyperactivity disorder in children. Annals of Allergy, 72, 564-568.
8. Brodie, K., & Sabshin, M. (1973). An overview of trends in psychiatric research: 1963-1972. The American Journal of Psychiatry, 130(12), 1309-1318.
9. Brown, B. S. (1976). The life of psychiatry. American Journal of Psychiatry, 133, 489-495.
10. Brown, P. (1990). The name game: Toward a sociology of diagnosis. The Journal of Mind and Behavior, 11(3-4), 385-406.
11. Brown, P. (1995). Naming and framing: The social construction of diagnosis and illness. Journal of Health and Social Behavior, 35, 34-52.
12. Bursztejn, C., & Golse, B. (2006). L'hyperactivité avec troubles de l'attention: Questions cliniques et é pistémologiques (Attention deficit/hyperactivity disorder: Clinical and epistemological issues). Neuropsychiatrie de l'enfance et de l'adolescence, 54, 29-37. (Pubitemid 43286832)
13. Carpiano, R. (2001). Passive medicalization: The case of Viagra and erectile dysfunction. Sociological Spectrum, 21, 441-450.
14. Conners, K. (1969). A teacher rating scale for use in doing studies with children. American Journal of Psychiatry, 126, 152-156.
15. Conners, C. K. (1990). Feeding the brain: How foods affect children. New York,NY: Plenum Press.
16. Conrad, P. (1976). Identifying hyperactive children: The medicalization of deviant behavior. Lexington, MA: Lexington Books.
17. Conrad, P. (1992). Medicalization and social control. Annual Review of Sociology, 18, 209-232.
18. Conrad, P. (2005). The shifting engines of medicalization. Journal of Health and Social Behavior, 46, 3-14. (Pubitemid 41503889)
19. Conrad, P. (2007). The medicalization of society: On the transformation of human conditions into treatable disorders. Baltimore, MD: John Hopkins University Press.
20. Conrad, P., & Leiter, V. (2008). From Lydia Pinham to Queen Levitra: Direct-to-consumer advertising and medicalisation. Sociology of Health and Illness, 30(6), 825-838.
21. Conrad, P., & Potter, D. (2000). From hyperactive children to ADHD adults: Observations on the expansion of medical categories. Social Problems, 47(4), 559-582. (Pubitemid 33231713)
22. Cooksey, E., & Brown, P. (1998). Spinning on its axes: DSM and the social construction of psychiatric diagnosis. International Journal of Health Services, 28(3), 525-554. (Pubitemid 28373288)
23. Cosgrove, L., Krimsky, S., Vijayaraghavan, M., & Schneider, L. (2006). Financial ties between DSM-IV panel members and the pharmaceutical industry. Psychotherapy and Psychosomatics, 75, 154-160.
24. Decker, H. (2007). How Kraepelinian was Kraepelin? How Kraepelinian are the neo-Kraepelinians? -From Emil Kraepelin to DSM-III. History of Psychiatry, 18(3), 337-360.
25. Dorozynski, A. (1996). France tackles psychotropic drug problem. British Medical News, 312, 997.
26. Egger, J., Carter, C., Graham, P., Gumley, D., & Soothill, J. (1985). Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome. Lancet, 1, 540-545. (Pubitemid 15101847)
27. Emsley, R., Myburgh, C., Oosthuizen, P., & Van Rensburg, S. J. (2002). Randomized placebocontrolled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia. American Journal of Psychiatry, 159(9), 1596-1598. (Pubitemid 35006744)
28. Fe'de'ration Franc-Aise de Psychiatrie. (2000). Classification Franc-Aise de Troubles Mentaux de l'Enfant et de l'Adolescent. Retrieved from http://psydocfr.broca.inserm.fr:16080/biblo-bd/cftmea/cftmea1b.html.
29. Feingold, B. (1976). Hyperkinesis and learning disabilities linked to the ingestion of artificial food colors and flavors. Journal of Learning Disabilities, 9, 19-27.
30. Fox, P. (1989). From senility to Alzheimer's disease: The rise of the Alzheimer's movement. Milbank Quarterly, 67, 58-101.
31. Frangou, S., Lewis, M., & McCrone, P. (2006). Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: Randomised double-blind placebo-controlled study. British Journal of Psychiatry, 188, 46-50. (Pubitemid 43021926)
32. Goffman, I. (1961). Asylums: Essays on the social situation of mental patients and other inmates. Garden City, NY: Anchor Books.
33. Hasanah, C., Khan, U., Musalmah, M., & Razali, S. (1997). Reduced red-cell folate in mania. Journal of Affective Disorders, 46, 95-99.
34. Healy, D. (2002). The creation of psychopharmacology. Cambridge,MA: Harvard University Press.
35. Horwitz, A. (2002). Creating mental illness. Chicago, IL: University of Chicago Press.
36. Horwitz, A. (2007). Transforming normality into pathology: The DSM and the outcomes of stressful arrangements. Journal of Health and Social Behavior, 48(3), 211-222.
37. Jacobson, M., & Schardt, D. (1999). Diet, ADHD, & behavior: A quarter-century review. Washington, DC: Center for Science in the Public Interest.
38. Johnson, M., Ostlund, S., Fransson, G., Kadesjo?, B., & Gillberg, C. (2009). Omega-3/Omega-6 fatty acids for attention deficit hyperactivity disorder: A randomized placebo-controlled trial in children and adolescents. Journal of Attention Disorder, 12(5), 394-401.
39. Kirk, S. (2004). Are children's DSM diagnoses accurate? Brief Treatment and Crisis Intervention, 4(3), 255-270.
40. Kirk, S., & Kutchins, H. (1992). The selling of DSM: The rhetoric of science in psychiatry. New York, NY: Aldine de Gruyter.
41. Kleinman, A. (1988). Rethinking psychiatry: From cultural category to personal experience. New York, NY: The Free Press.
42. Konofal, E., Lecendreux, M., Deron, J., Marchand, M., Cortese, S., Zai?m, M., y Arnulf, I. (2008). Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatric Neurology, 38(1), 20-26. (Pubitemid 350181289)
43. Krager, J., Safer, D., & Earhart, J. (1979). Follow-up survey results of medication used to treat hyperactive school children. The Journal of School Health, 49(6), 317-321.
44. Kutchins, H., & Kirk, S. (1997). Making us crazy, DSM: The psychiatric Bible and the creation of mental disorders. New York, NY: The Free Press.
45. Laing, R. (1960). The divided self: A study of sanity and madness. London, England: Tavistock Press.
46. Lakoff, A. (2000). Adaptive will: The evolution of attention deficit disorder. Journal of the History of the Behavioral Sciences, 36(2), 149-169.
47. Lakoff, A. (2005). Pharmaceutical reason: Knowledge and value in global psychiatry. New York, NY: Cambridge University Press.
48. Le Heuzey, M. F. (2006). Traitements médicaux de l'enfant hyperactif: A propos des deux nouvelles formes de methylphenidate commercialisées en France (Medical treatments for the hyperactive child: Regarding two new forms of methylphenidate marketed in France). Archives de Pédiatrie, 13, 100-103.
49. Mayes, R., & Horwitz, A. (2005). DSM-III and the revolution in the classification of mental illness. Journal of the Behavior of the Behavioral Sciences, 41(3), 249-267. (Pubitemid 41311768)
50. McCann, D., Barrett, A.,Cooper, A.,Crumpler, D.,Dalen, L., Grimshaw, K.,&Kitchin, E. (2007). Food additives and hyperactive behaviour in 3-year-old and 8/9 children in the community: A randomised, double-blinded, placebo-controlled trial. Lancet, 370, 1560-1567. (Pubitemid 350018874)
51. McKinlay, J. (2009). A case of refocusing upstream: The political economy of illness. In: P. Conrad (Ed.), The sociology of health and illness: Critical perspectives (pp. 578-591). New York, NY: Worth Publishers.
52. Menninger, K. (1963). The vital balance. New York, NY: Viking Press.
53. Mise s, R., Quemada, N., Botbol, M., Burzstejn, C., Garrabé, J., Golse, B., y Thevenot, J. P. (2002). French classification for child and adolescent mental disorders. Psychopathology, 35, 176-180.
54. Nefsky, C. (2004). A conceptual history of attention deficit and hyperactivity disorder. Retrieved from http://www.medicine.uottawa.ca/ historyofmedicine/hetenyi/nefsky.htm.
55. Ohayon, A. (2006). Psychologie et psychanalyse en France: L'impossible rencontre (1919-1969). Paris, France: La De'couverte.
56. Payer, L. (1996). Medicine and culture: Varieties of treatment in the United States, England, West Germany, and France. New York, NY: Henry Holt and Company.
57. Peet, M. (2003). Eicosapentaenoic acid in the treatment of schizophrenia and depression: Rationale and preliminary double-blind clinical test results. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 69(6), 477-485. (Pubitemid 37464058)
58. Plakun, E. M. (2006). Finding psychodynamic psychiatry's lost generation. Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry, 34(1), 135-150.
59. Raynaud, J. P. (1999). Hyperactivité de l'enfant: Pour une approche prudente, pluridisciplinaire et concertée (Childhood hyperactivity: For a safe, multi-disciplinary and concerted approach). Approches Neuropsychologique des Apprentissages chez l'Enfant, 53-54, 95-97.
60. Roudinesco, E. (2004). Le patient, le the'rapeute et l'Etat. Paris, France: Fayard.
61. Sabshin, M. (1990). Turning points in twentieth-century American psychiatry. American Journal of Psychiatry, 147(10), 1267-1274. (Pubitemid 20346260)
62. Safer, D., & Krager, J. (1985). Prevalence of medication treatment for hyperactive adolescents. Psychopharmacological Bulletin, 21(2), 212-215. (Pubitemid 15114521)
63. Safer, D., & Krager, J. (1994). The increased rate of stimulant treatment for hyperactive/inattentive students in secondary schools. Pediatrics, 94(4), 462-464. (Pubitemid 24295022)
64. Safer, D., Zito, J., & Fine, E. (1996). Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics, 98(6), 1084-1088. (Pubitemid 26399270)
65. Schapiro, M. (2007). Exposed: The toxic chemistry of everyday products. Who's at risk and what's at stake for American power. White River Junction, VT: Chelsea Green Publishing.
66. Stoll, A. L., Severus, W. E., Freeman, M. P., Rueter, S., Zboyan, H. A., Diamond, E., y Marangell, L. B. (1999). Omega 3 fatty acids in bipolar disorder: A preliminary doubleblind, placebo-controlled trial. Archives of General Psychiatry, 56(5), 407-412. (Pubitemid 29215428)
67. Szasz, T. (1960). The myth of mental illness. The American Psychologist, 15(2), 113-118.
68. Tiefer, L. (1994). Three crises facing sexology. Archives of Sexual Behavior, 23(4), 361-374. (Pubitemid 24239250)
69. Watters, E. (2010). Crazy like us: The globalization of the American psyche. New York, NY: The Free Press.
70. Wilson, M. (1993). DSM-III and the transformation of American psychiatry: A history. American Journal of Psychiatry, 150(3), 399-410.
71. Yao, J., Magan, S., Sonel, A., Gurklis, J., Sanders, R., & Reddy, R. (2004). Effects of omega-3 fatty acid on platelet serotonin responsivity in patients with schizophrenia. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 71(3), 171-176. (Pubitemid 38903062)
72. Young, SN. (2007). Folate and depression -A neglected problem. Journal of Psychiatry Neuroscience, 32(2), 80-82.
73. Zito, J., Safer, D. J., DosReis, S., Gardner, J. F., Magder, L., Soeken, K., y Riddle, M. A. (2003). Psychotropic practice patterns for youth: A 10-year perspective. Archives of Pediatrics and Adolescent Medicine, 157(1), 17-25. (Pubitemid 36343413)
74. Zola, I. K. (1972). Medicine as an institution of social control. Sociological Review, 20, 487-503.